Profile data is unavailable for this security.
About the company
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.
- Revenue in USD (TTM)1.71bn
- Net income in USD-54.37m
- Incorporated1998
- Employees6.55k
- LocationEnovis Corp2711 CENTERVILLE ROAD, SUITE 400WILMINGTON 19808United StatesUSA
- Phone+1 (302) 252-9160
- Fax+1 (301) 323-9001
- Websitehttps://www.enovis.com/
Mergers & acquisitions
Acquired company | ENOV:NYQ since announced | Transaction value |
---|---|---|
Limacorporate SpA | 20.91% | 852.16m |
Novastep SAS | 16.75% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TransMedics Group Inc | 241.62m | -25.03m | 2.42bn | 584.00 | -- | 17.65 | -- | 10.04 | -0.7685 | -0.7685 | 7.43 | 4.20 | 0.4915 | 2.70 | 5.30 | 413,738.00 | -5.09 | -16.08 | -5.53 | -17.95 | 63.77 | 65.37 | -10.36 | -40.47 | 8.49 | -- | 0.7868 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
Conmed Corp | 1.24bn | 64.46m | 2.47bn | 4.00k | 39.26 | 2.96 | 18.09 | 1.98 | 2.04 | 2.04 | 39.67 | 27.12 | 0.5415 | 1.75 | 5.74 | 311,185.80 | 2.80 | 0.8972 | 3.23 | 1.02 | 54.33 | 54.95 | 5.18 | 1.65 | 0.9569 | 3.03 | 0.5386 | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
ICU Medical Inc | 2.26bn | -29.66m | 2.48bn | 14.00k | -- | 1.17 | 12.41 | 1.10 | -1.23 | -1.23 | 93.55 | 87.96 | 0.5080 | 2.16 | 11.79 | 161,366.10 | -0.6669 | 1.46 | -0.7491 | 1.65 | 32.75 | 34.11 | -1.31 | 2.23 | 1.06 | 0.6484 | 0.4345 | 0.00 | -0.9154 | 10.04 | 60.08 | -- | -1.45 | -- |
Procept Biorobotics Corp | 136.19m | -105.90m | 2.49bn | 626.00 | -- | 8.83 | -- | 18.28 | -2.24 | -2.24 | 2.88 | 5.53 | 0.3815 | 1.91 | 4.28 | 217,557.50 | -29.66 | -- | -33.47 | -- | 52.17 | -- | -77.75 | -- | 6.77 | -- | 0.1546 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
Patterson Companies, Inc. | 6.57bn | 193.86m | 2.49bn | 7.60k | 13.70 | 2.58 | 8.89 | 0.3792 | 2.03 | 2.03 | 68.86 | 10.78 | 2.23 | 5.61 | 14.48 | 864,047.90 | 6.58 | 0.3702 | 11.30 | 0.5655 | 21.30 | 21.05 | 2.95 | 0.1811 | 0.7243 | 12.08 | 0.4462 | 846.10 | -0.4298 | 3.44 | 2.14 | 10.79 | 8.22 | 0.00 |
Premier Inc | 1.32bn | 167.33m | 2.61bn | 2.80k | 15.64 | 1.09 | 8.88 | 1.98 | 1.39 | 1.39 | 10.97 | 19.95 | 0.3571 | 4.57 | 3.06 | 470,033.20 | 4.42 | 10.39 | 5.67 | 13.00 | 67.13 | 62.04 | 12.37 | 22.60 | 1.32 | 516.34 | 0.2431 | 19.11 | -6.76 | 2.44 | -34.17 | -15.30 | -2.29 | -- |
Helen of Troy Limited | 2.00bn | 162.04m | 2.73bn | 1.90k | 17.00 | 1.72 | 12.97 | 1.36 | 6.76 | 6.76 | 83.27 | 66.81 | 0.6579 | 2.25 | 4.13 | 1,051,199.00 | 5.33 | 8.62 | 6.46 | 10.82 | 45.95 | 43.16 | 8.10 | 9.72 | 0.9755 | 4.82 | 0.3168 | -- | -6.78 | 6.98 | -35.97 | -0.488 | 66.65 | -- |
Inari Medical Inc | 493.63m | -1.64m | 2.75bn | 1.30k | -- | 5.89 | 522.90 | 5.57 | -0.0318 | -0.0318 | 8.60 | 8.05 | 0.8378 | 1.57 | 7.67 | 379,716.90 | -0.2777 | -0.5941 | -0.3129 | -0.6696 | 88.03 | 89.06 | -0.3314 | -0.6295 | 2.52 | -- | 0.00 | -- | 28.73 | 135.40 | 94.41 | -- | 52.46 | -- |
LivaNova PLC | 1.15bn | 17.55m | 3.01bn | 2.90k | 173.39 | 2.36 | 44.42 | 2.61 | 0.3222 | 0.3222 | 21.32 | 23.70 | 0.4883 | 2.76 | 5.79 | 397,774.10 | 0.7472 | -6.01 | 0.8627 | -7.42 | 66.86 | 66.99 | 1.53 | -13.56 | 2.51 | 1.10 | 0.3147 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
Enovis Corp | 1.71bn | -54.37m | 3.41bn | 6.55k | -- | 0.9976 | 20.90 | 2.00 | -0.9987 | -0.6117 | 31.33 | 62.61 | 0.3888 | 1.59 | 6.11 | 260,640.80 | -1.23 | -0.3569 | -1.37 | -0.41 | 58.21 | 48.19 | -3.15 | -1.06 | 1.16 | 1.02 | 0.1199 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
Axonics Inc | 366.38m | -6.09m | 3.51bn | 797.00 | -- | 5.49 | 551.15 | 9.59 | -0.1285 | -0.1285 | 7.43 | 12.56 | 0.5313 | 1.35 | 7.18 | 459,697.60 | -0.8828 | -12.67 | -0.9601 | -13.76 | 74.94 | 70.04 | -1.66 | -29.68 | 8.98 | -- | 0.00 | -- | 33.86 | 249.06 | 89.80 | -- | 23.65 | -- |
Envista Holdings Corp | 2.57bn | -100.20m | 3.70bn | 12.80k | -- | 0.8855 | 104.43 | 1.44 | -0.6022 | -0.6022 | 14.65 | 24.34 | 0.3891 | 3.99 | 6.41 | 200,507.80 | -1.52 | 1.94 | -1.79 | 2.34 | 56.52 | 57.65 | -3.90 | 5.29 | 1.90 | 5.12 | 0.2661 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
Integer Holdings Corp | 1.60bn | 90.65m | 3.84bn | 10.50k | 42.88 | 2.52 | 20.28 | 2.41 | 2.68 | 2.68 | 47.30 | 45.58 | 0.5566 | 5.25 | 5.15 | 152,064.10 | 3.16 | 3.28 | 3.43 | 3.53 | 26.30 | 26.94 | 5.68 | 6.40 | 1.71 | 3.54 | 0.3898 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
Lantheus Holdings Inc | 1.30bn | 326.66m | 4.14bn | 834.00 | 13.03 | 5.08 | 10.72 | 3.20 | 4.64 | 4.64 | 18.59 | 11.91 | 0.8723 | 9.46 | 5.21 | 1,554,471.00 | 21.98 | 6.69 | 25.75 | 7.73 | 63.71 | 53.90 | 25.20 | 9.02 | 5.45 | 1,235.43 | 0.4081 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
Haemonetics Corporation | 1.27bn | 126.57m | 4.27bn | 3.03k | 34.03 | 4.53 | 19.41 | 3.36 | 2.47 | 2.47 | 24.80 | 18.57 | 0.6229 | 2.11 | 6.47 | 418,649.00 | 6.21 | 4.74 | 7.05 | 5.89 | 53.48 | 49.77 | 9.97 | 7.41 | 1.76 | 25.45 | 0.48 | 0.00 | 17.67 | 5.27 | 166.05 | 9.48 | 8.06 | -- |
Merit Medical Systems Inc | 1.26bn | 94.41m | 4.37bn | 6.95k | 46.64 | 3.63 | 23.71 | 3.48 | 1.62 | 1.62 | 21.55 | 20.78 | 0.6304 | 2.36 | 7.34 | 180,916.00 | 4.73 | 2.45 | 5.30 | 2.77 | 46.44 | 44.50 | 7.51 | 3.91 | 3.95 | 9.89 | 0.4064 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
Holder | Shares | % Held |
---|---|---|
T. Rowe Price Investment Management, Inc.as of 31 Dec 2023 | 6.58m | 12.05% |
The Vanguard Group, Inc.as of 31 Dec 2023 | 4.83m | 8.85% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 4.42m | 8.10% |
Dimensional Fund Advisors LPas of 31 Dec 2023 | 3.19m | 5.85% |
Diamond Hill Capital Management, Inc.as of 31 Dec 2023 | 2.51m | 4.59% |
Select Equity Group LPas of 31 Dec 2023 | 2.45m | 4.49% |
Davenport & Co. LLCas of 31 Dec 2023 | 1.88m | 3.44% |
Thrivent Asset Management LLCas of 31 Dec 2023 | 1.80m | 3.30% |
Millennium Management LLCas of 31 Dec 2023 | 1.64m | 3.00% |
Royce & Associates LPas of 31 Dec 2023 | 1.59m | 2.92% |